OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)
South Korea · Delayed Price · Currency is KRW 10,800
-2,970 (-21.57%)
At close: Apr 2, 2026
OPTUS Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 11,358 | 10,308 | 10,760 | 5,012 | 9,892 |
Depreciation & Amortization | 4,708 | 3,977 | 4,238 | 3,463 | 2,423 |
Loss (Gain) From Sale of Assets | 32.58 | 2.15 | -295.22 | -796.74 | -10.25 |
Loss (Gain) From Sale of Investments | -452.02 | -1,686 | -2,301 | 566.27 | 930.99 |
Stock-Based Compensation | -503.28 | 519.16 | 81.41 | - | - |
Provision & Write-off of Bad Debts | -0.03 | 0.02 | -15.04 | -0.09 | - |
Other Operating Activities | 1,746 | 2,069 | 2,771 | 646.69 | -397.52 |
Change in Accounts Receivable | 2,465 | -4,171 | -1,852 | -1,151 | -2,438 |
Change in Inventory | -2,564 | -77.42 | -1,800 | -2,112 | -3,043 |
Change in Accounts Payable | -885.2 | 1,235 | 352.75 | 17.23 | 306.46 |
Change in Other Net Operating Assets | 319.97 | -3,272 | 497.8 | -3,601 | -592.48 |
Operating Cash Flow | 16,225 | 8,905 | 12,438 | 2,045 | 7,071 |
Operating Cash Flow Growth | 82.21% | -28.41% | 508.12% | -71.08% | -59.47% |
Capital Expenditures | -44,515 | -11,808 | -3,329 | -6,001 | -10,628 |
Sale of Property, Plant & Equipment | 6 | 10.82 | 683.79 | 1,292 | 2.9 |
Sale (Purchase) of Intangibles | -526.38 | -13,932 | - | - | - |
Investment in Securities | 13,228 | 27,990 | -173.08 | -10,998 | -4,606 |
Other Investing Activities | -4.07 | -16.3 | -78.03 | -536.23 | 12.32 |
Investing Cash Flow | -31,790 | 2,290 | -2,929 | -16,266 | -15,223 |
Short-Term Debt Issued | - | 1 | - | - | - |
Total Debt Issued | - | 1 | - | - | - |
Short-Term Debt Repaid | - | -1 | - | - | - |
Long-Term Debt Repaid | -751.86 | -730.47 | -588.39 | -364.67 | -111.24 |
Total Debt Repaid | -751.86 | -731.47 | -588.39 | -364.67 | -111.24 |
Net Debt Issued (Repaid) | -751.86 | -730.47 | -588.39 | -364.67 | -111.24 |
Issuance of Common Stock | 10,090 | 117.57 | - | - | - |
Repurchase of Common Stock | - | - | - | -5,958 | - |
Dividends Paid | - | -1,526 | -1,517 | -1,604 | -1,604 |
Other Financing Activities | -7.67 | - | - | - | - |
Financing Cash Flow | 9,331 | -2,139 | -2,105 | -7,927 | -1,715 |
Foreign Exchange Rate Adjustments | 0.15 | 39.17 | -2.25 | 1.05 | - |
Miscellaneous Cash Flow Adjustments | - | - | - | - | -0 |
Net Cash Flow | -6,234 | 9,095 | 7,402 | -22,146 | -9,867 |
Free Cash Flow | -28,290 | -2,903 | 9,109 | -3,955 | -3,557 |
Free Cash Flow Margin | -32.46% | -3.55% | 12.58% | -6.74% | -6.21% |
Free Cash Flow Per Share | -1818.26 | -190.11 | 599.63 | -249.37 | -221.87 |
Cash Interest Paid | - | 0 | 120.16 | 83.85 | - |
Cash Income Tax Paid | 888.55 | 2,175 | 930.79 | 2,094 | 2,075 |
Levered Free Cash Flow | -31,716 | -11,169 | 5,838 | -4,902 | -4,264 |
Unlevered Free Cash Flow | -31,673 | -11,108 | 5,915 | -4,848 | -4,258 |
Change in Working Capital | -664.66 | -6,285 | -2,801 | -6,846 | -5,767 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.